US Stock MarketDetailed Quotes

CNSP CNS Pharmaceuticals

Watchlist

3.4500
-0.2000-5.48%

Close Jun 11 16:00 ET

1.35MMarket Cap-24P/E (TTM)

CNS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

33.84%-3.19M

-33.93%-14.14M

-10.02%-2.54M

-86.25%-3.38M

-1.20%-3.4M

-56.79%-4.82M

22.02%-10.56M

28.78%-2.31M

9.16%-1.81M

32.72%-3.36M

Net income from continuing operations

28.13%-3.54M

-23.42%-18.85M

-4.64%-5.38M

-32.26%-4.52M

-12.77%-4.02M

-56.48%-4.93M

-5.37%-15.27M

-57.87%-5.14M

10.35%-3.42M

6.50%-3.57M

Operating gains losses

---190

-83.99%498

-154.41%-259

----

--3.11K

--476

--1.17K

----

Depreciation and amortization

-36.04%818

-64.83%4.13K

-59.97%953

-67.82%899

-68.71%1K

-62.10%1.28K

-10.05%11.76K

-31.84%2.38K

-17.07%2.79K

-0.12%3.21K

Change In working capital

180.94%149.13K

16.90%3.7M

18.17%2.61M

-27.65%950.06K

472.09%327.79K

30.60%-184.24K

505.67%3.16M

826.64%2.2M

0.33%1.31M

94.68%-88.1K

-Change in prepaid assets

-85.12%102.99K

176.28%2.38M

391.67%800.26K

-13.89%753.94K

322.43%130.85K

117.60%692.22K

156.60%860.45K

-86.62%-274.37K

87.66%875.53K

96.58%-58.83K

-Change in payables and accrued expense

105.26%46.14K

-42.62%1.32M

-27.18%1.81M

-55.18%196.12K

772.87%196.94K

-50.18%-876.46K

211.23%2.3M

1,685.14%2.48M

-38.34%437.58K

-148.34%-29.27K

Cash from discontinued investing activities

Operating cash flow

33.84%-3.19M

-33.93%-14.14M

-10.02%-2.54M

-86.25%-3.38M

-1.20%-3.4M

-56.79%-4.82M

22.02%-10.56M

28.78%-2.31M

9.16%-1.81M

32.72%-3.36M

Investing cash flow

Cash flow from continuing investing activities

11.78%-3.9K

-215,800.00%-2.16K

-15.19%-1.74K

23.07%-4.42K

100.05%1

-1.51K

Net PPE purchase and sale

----

11.78%-3.9K

-215,800.00%-2.16K

-15.19%-1.74K

----

23.07%-4.42K

100.05%1

---1.51K

----

Cash from discontinued investing activities

Investing cash flow

----

11.78%-3.9K

-215,800.00%-2.16K

-15.19%-1.74K

----

23.07%-4.42K

100.05%1

---1.51K

----

Financing cash flow

Cash flow from continuing financing activities

2,975.33%3.46M

-70.30%4.64M

-59.17%2.18M

107.14%8.36K

2,313.46%2.57M

-101.14%-120.28K

246.26%15.61M

6,538.96%5.33M

-103.41%-117.14K

-114.37%-116.18K

Net issuance payments of debt

27.45%-87.7K

-2.58%-438.73K

10.73%-70.67K

-6.28%-124.49K

-5.60%-122.68K

-4.92%-120.89K

10.43%-427.7K

4.42%-79.17K

11.89%-117.14K

11.69%-116.18K

Net common stock issuance

--3.53M

-85.55%2.32M

-96.02%215.64K

--132.85K

--1.97M

--0

244.62%16.04M

--5.41M

--0

Proceeds from stock option exercised by employees

1,936.95%12.41K

108,211.59%2.96M

1,894,451.69%2.24M

--0

--725.06K

-76.72%609

-99.18%2.73K

--118

--0

Net other financing activities

----

---202.86K

----

Cash from discontinued financing activities

Financing cash flow

2,975.33%3.46M

-70.30%4.64M

-59.17%2.18M

107.14%8.36K

2,313.46%2.57M

-101.14%-120.28K

246.26%15.61M

6,538.96%5.33M

-103.41%-117.14K

-114.37%-116.18K

Net cash flow

Beginning cash position

-94.54%548.72K

100.93%10.06M

-87.06%909.55K

-52.23%4.28M

-58.92%5.11M

100.93%10.06M

-64.35%5M

-15.60%7.03M

30.11%8.96M

12.33%12.44M

Current changes in cash

105.39%266.51K

-288.22%-9.51M

-111.92%-360.83K

-74.47%-3.37M

76.12%-831.28K

-166.50%-4.94M

155.90%5.05M

191.16%3.03M

-234.07%-1.93M

16.90%-3.48M

End cash Position

-84.05%815.23K

-94.54%548.72K

-87.06%909.55K

-52.23%4.28M

-58.92%5.11M

100.93%10.06M

-15.60%7.03M

30.11%8.96M

Free cash flow

33.84%-3.19M

-33.91%-14.14M

-10.12%-2.54M

-86.19%-3.38M

-1.11%-3.4M

-56.79%-4.82M

22.02%-10.56M

28.82%-2.31M

9.08%-1.81M

32.66%-3.37M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	33.84%-3.19M	-33.93%-14.14M	-10.02%-2.54M	-86.25%-3.38M	-1.20%-3.4M	-56.79%-4.82M	22.02%-10.56M	28.78%-2.31M	9.16%-1.81M	32.72%-3.36M
Net income from continuing operations	28.13%-3.54M	-23.42%-18.85M	-4.64%-5.38M	-32.26%-4.52M	-12.77%-4.02M	-56.48%-4.93M	-5.37%-15.27M	-57.87%-5.14M	10.35%-3.42M	6.50%-3.57M
Operating gains losses	---190	-83.99%498	-154.41%-259	----	----	----	--3.11K	--476	--1.17K	----
Depreciation and amortization	-36.04%818	-64.83%4.13K	-59.97%953	-67.82%899	-68.71%1K	-62.10%1.28K	-10.05%11.76K	-31.84%2.38K	-17.07%2.79K	-0.12%3.21K
Change In working capital	180.94%149.13K	16.90%3.7M	18.17%2.61M	-27.65%950.06K	472.09%327.79K	30.60%-184.24K	505.67%3.16M	826.64%2.2M	0.33%1.31M	94.68%-88.1K
-Change in prepaid assets	-85.12%102.99K	176.28%2.38M	391.67%800.26K	-13.89%753.94K	322.43%130.85K	117.60%692.22K	156.60%860.45K	-86.62%-274.37K	87.66%875.53K	96.58%-58.83K
-Change in payables and accrued expense	105.26%46.14K	-42.62%1.32M	-27.18%1.81M	-55.18%196.12K	772.87%196.94K	-50.18%-876.46K	211.23%2.3M	1,685.14%2.48M	-38.34%437.58K	-148.34%-29.27K
Cash from discontinued investing activities
Operating cash flow	33.84%-3.19M	-33.93%-14.14M	-10.02%-2.54M	-86.25%-3.38M	-1.20%-3.4M	-56.79%-4.82M	22.02%-10.56M	28.78%-2.31M	9.16%-1.81M	32.72%-3.36M
Investing cash flow
Cash flow from continuing investing activities		11.78%-3.9K	-215,800.00%-2.16K	-15.19%-1.74K			23.07%-4.42K	100.05%1	-1.51K
Net PPE purchase and sale	----	11.78%-3.9K	-215,800.00%-2.16K	-15.19%-1.74K	----	----	23.07%-4.42K	100.05%1	---1.51K	----
Cash from discontinued investing activities
Investing cash flow	----	11.78%-3.9K	-215,800.00%-2.16K	-15.19%-1.74K	----	----	23.07%-4.42K	100.05%1	---1.51K	----
Financing cash flow
Cash flow from continuing financing activities	2,975.33%3.46M	-70.30%4.64M	-59.17%2.18M	107.14%8.36K	2,313.46%2.57M	-101.14%-120.28K	246.26%15.61M	6,538.96%5.33M	-103.41%-117.14K	-114.37%-116.18K
Net issuance payments of debt	27.45%-87.7K	-2.58%-438.73K	10.73%-70.67K	-6.28%-124.49K	-5.60%-122.68K	-4.92%-120.89K	10.43%-427.7K	4.42%-79.17K	11.89%-117.14K	11.69%-116.18K
Net common stock issuance	--3.53M	-85.55%2.32M	-96.02%215.64K	--132.85K	--1.97M	--0	244.62%16.04M	--5.41M	--0	--0
Proceeds from stock option exercised by employees	1,936.95%12.41K	108,211.59%2.96M	1,894,451.69%2.24M	--0	--725.06K	-76.72%609	-99.18%2.73K	--118	--0	--0
Net other financing activities	----	---202.86K	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	2,975.33%3.46M	-70.30%4.64M	-59.17%2.18M	107.14%8.36K	2,313.46%2.57M	-101.14%-120.28K	246.26%15.61M	6,538.96%5.33M	-103.41%-117.14K	-114.37%-116.18K
Net cash flow
Beginning cash position	-94.54%548.72K	100.93%10.06M	-87.06%909.55K	-52.23%4.28M	-58.92%5.11M	100.93%10.06M	-64.35%5M	-15.60%7.03M	30.11%8.96M	12.33%12.44M
Current changes in cash	105.39%266.51K	-288.22%-9.51M	-111.92%-360.83K	-74.47%-3.37M	76.12%-831.28K	-166.50%-4.94M	155.90%5.05M	191.16%3.03M	-234.07%-1.93M	16.90%-3.48M
End cash Position	-84.05%815.23K	-94.54%548.72K	-94.54%548.72K	-87.06%909.55K	-52.23%4.28M	-58.92%5.11M	100.93%10.06M	100.93%10.06M	-15.60%7.03M	30.11%8.96M
Free cash flow	33.84%-3.19M	-33.91%-14.14M	-10.12%-2.54M	-86.19%-3.38M	-1.11%-3.4M	-56.79%-4.82M	22.02%-10.56M	28.82%-2.31M	9.08%-1.81M	32.66%-3.37M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall